BSGM:NSD-BioSig Technologies Inc (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 1.77

Change

-0.05 (-2.75)%

Market Cap

USD 0.06B

Volume

0.17M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


BioSig Technologies Inc (BSGM) Stock Analysis:
Based on the BioSig Technologies Inc stock forecasts from 0 analysts, the average analyst target price for BioSig Technologies Inc is not available over the next 12 months. BioSig Technologies Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BioSig Technologies Inc is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, BioSig Technologies Inc’s stock price was USD 1.77. BioSig Technologies Inc’s stock price has changed by -0.26% over the past week, -0.93% over the past month and -61.61% over the last year.

No recent analyst target price found for BioSig Technologies Inc
No recent average analyst rating found for BioSig Technologies Inc

About

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hard ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-01-25 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DXCM DexCom Inc

-20.60 (-4.83%)

USD41.37B 80.50 117.62
ALGN Align Technology Inc

-6.44 (-1.36%)

USD36.49B 49.88 48.05
PODD Insulet Corporation

-11.18 (-5.01%)

USD15.46B 2,208.27 199.97
LVGO Livongo Health, Inc

N/A

USD14.20B N/A N/A
ABMD Abiomed Inc

-15.10 (-4.84%)

USD14.19B 95.78 46.15
BRKR Bruker Corporation

-2.97 (-4.39%)

USD10.02B 37.31 25.78
TNDM Tandem Diabetes Care Inc

-8.15 (-6.51%)

USD7.96B 369.41 187.52
IART Integra LifeSciences Holdings ..

-1.77 (-2.63%)

USD5.64B 26.21 17.89
SWAV ShockWave Medical Inc

-8.56 (-5.98%)

USD4.75B N/A N/A
LIVN LivaNova PLC

-3.11 (-3.90%)

USD4.25B 77.40 N/A

ETFs Containing BSGM

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -20.63% 36% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -20.63% 36% F 25% F
Trailing 12 Months  
Capital Gain -61.61% 30% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -61.61% 30% F 19% F
Trailing 5 Years  
Capital Gain 17.22% 55% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.22% 55% F 42% F
Average Annual (5 Year Horizon)  
Capital Gain 60.83% 80% B- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 60.83% 80% B- 88% B+
Risk Return Profile  
Volatility (Standard Deviation) 120.06% 21% F 12% F
Risk Adjusted Return 50.67% 74% C 71% C-
Market Capitalization 0.06B 28% F 17% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 4.50 45% F 28% F
Price / Cash Flow Ratio -2.39 42% F 61% D-
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -143.01% 17% F 8% F
Return on Invested Capital -330.30% 2% F 2% F
Return on Assets -78.02% 9% F 2% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio 6.98 15% F 11% F
Short Percent 6.54% 19% F 25% F
Beta 1.55 30% F 24% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector